First human tests begin for potential neurological disorder drug
Knowledge-focused
Completed
This early-stage study tested the safety of a new capsule called GTB in 40 healthy volunteers. Researchers gave participants single and then multiple doses to check for side effects and see how the body processes the drug. The goal was to gather basic safety information before te…
Phase: PHASE1 • Sponsor: Forest Hills Lab • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC